Stereotaxis Inc (STXS)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Stereotaxis Inc Stock (STXS) Company Profile

Stereotaxis Inc

Healthcare (1100)

314-678-6100

4320 Forest Park Avenue, Suite 100, St. Louis, MO

@stereotaxis

Nächster Verdiensttermin

Neueste SEC-Einreichungen

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, MDLN, ALC, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STXS Stereotaxis Inc	1.89	168.11M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	432.83	140.84B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	155.54	41.70B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.75	33.35B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	68.33	32.72B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	218.40	28.27B	5.54B	1.52B	1.74B	10.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-16	Eingeleitet	Citizens JMP	Mkt Outperform
2024-01-10	Eingeleitet	ROTH MKM	Buy
2022-07-12	Eingeleitet	Aegis Capital	Buy
2022-06-23	Eingeleitet	B. Riley Securities	Buy
2022-01-05	Eingeleitet	Craig Hallum	Buy
2022-01-05	Eingeleitet	Loop Capital	Buy
2021-05-26	Eingeleitet	Piper Sandler	Overweight
2020-09-08	Eingeleitet	Northland Capital	Outperform
2020-04-09	Eingeleitet	Cowen	Outperform
2020-04-07	Eingeleitet	Lake Street	Buy

Alle ansehen

Stereotaxis Inc Aktie (STXS) Neueste Nachrichten

Finanzdaten der Stereotaxis Inc-Aktie (STXS)

Stereotaxis Inc-Aktie (STXS) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Isaac Paul J	Director	Nov 17 '25	Buy	2.18	10,000	21,800	97,299

Stereotaxis Inc (STXS)

Stereotaxis Inc Stock (STXS) Company Profile

Compare STXS vs ISRG, BDX, MDLN, ALC, RMD

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Stereotaxis Inc Aktie (STXS) Neueste Nachrichten

Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan

Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan

Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan

Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union

Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

STXSStereotaxis Inc Options - Finviz

Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo

8 Most Promising Robotics Stocks Now - Insider Monkey

Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView

Stereotaxis, Inc. Actuals & Estimates (DUS:RJR1) - TradingView

STXS Forecast — Price Target — Prediction for 2027 - TradingView

Stereotaxis | 4: Statement of changes in beneficial ownership of securities-Officer Peery Kimberly R. - Moomoo

Stereotaxis Inc (STXS) Institutional Confidence - TradingKey

Stereotaxis, Inc. publishes new robotics case study in electrophysiology - Traders Union

Top Endovascular Robotic Systems Companies Driving the Future of Vascular Care - Fortune Business Insights

STXS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Stereotaxis, Inc. unveils online demo platform for advanced robotic cath lab - Traders Union

Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Stereotaxis Inc (STXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Stereotaxis, Inc. unveils Synchrony system to enhance cath lab workflow with single high resolution display - Traders Union

Q1 2026 Stereotaxis Inc Earnings Call Transcript - GuruFocus

Stereotaxis eyes billions in market opportunity with Robocath takeover - MSN

MAGiC system delivers enhanced precision and control in arrhythmia care - Traders Union

Stereotaxis (STXS) Stock Price, News & Analysis $STXS - MarketBeat

Stereotaxis Inc (NYSE: STXS) Share Price, STXS Stock News, STXS Share Price & Updates - Kalkine

Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy - Traders Union

Stereotaxis, Inc. unveils remote access technology in cardiology test drive event - Traders Union

Citizens reiterates Stereotaxis stock rating on growth outlook By Investing.com - Investing.com South Africa

Citizens reiterates Stereotaxis stock rating on growth outlook - Investing.com

STXS Q1 2026 Earnings: Wider-than-Expected Loss Amidst Revenue ChallengesFree Cash Flow Trends - newsline.com

STXS Q1 2026 Earnings: EPS Misses Estimates as Losses WidenEarnings Trend Analysis - newsline.com

Stereotaxis Inc. (STXS) Slips 4.8% – Testing Key Support at $1.88TPO Profile - The Legal Advocate

Stereotaxis Inc. (STXS) Faces Selling Pressure as Shares Slide to $1.98Ratio Spread Trade - The Legal Advocate

Stereotaxis, Inc. advances robotic precision to transform patient care - Traders Union

Stereotaxis stock up on first US MAGIC procedures post approval - MSN

Stereotaxis Inches Upwards as Shares Approach Resistance at $2.02KAMA Signal - The Legal Advocate

Stereotaxis (STXS) Edges Higher: Navigating the Robotics Sector with Modest GainsVolatility Term Structure - Newser

Stereotaxis Emerges as Notable Oversold Play in AI Sector with Over 120 Percent Implied Upside - HarianBasis.co

Finanzdaten der Stereotaxis Inc-Aktie (STXS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Stereotaxis Inc-Aktie (STXS) Insiderhandel

Ähnlich wie STXS